FIMM HiLIFE Unit logo black
The Ripatti group studies genetics of common complex diseases from discovery to translation to health care. We utilize Finnish research cohorts and a global network of biobank data with longitudinal health event histories to identify genetic associations and potential causal variants modifying the risks of diseases. We also develop and test risk models to stratify individuals based on their risks for preventive actions or stratified treatment. With health care partners, we develop approaches to apply these models in routine health care.
Institute for Molecular Medicine Finland FIMM

Follow us on Twitter

@CoECDG

"Vår äldre bror som inte är läkare brukar fråga om vi får timpenning då vi pratar om diabetes" – bröderna Per-Henri… twitter.com/i/web/status/1…

135 000 suomalaisen tutkimusaineistoon perustuvat geneettiset tutkimustulokset on avattu vapaasti kansainvälisen tu… twitter.com/i/web/status/1…

1800 GWASes on 135,000 Finns with full summary stats, please enjoy twitter.com/FinnGen_FI/sta…

A highly Finnish enriched LoF in ANGPTL8 is associated with lower triglyceride levels, lower CAD risk but elevated… twitter.com/i/web/status/1…